G 206 (Moexipril and Hydrochlorothiazide 12.5 mg / 15 mg)

Pill imprint G 206 has been identified as Hydrochlorothiazide and moexipril hydrochloride 12.5 mg / 15 mg.

Moexipril is used in the treatment of diabetic kidney disease; left ventricular dysfunction; high blood pressure; heart failure; heart attack and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Moexipril 12.5 mg / 15 mg is not a controlled substance under the Controlled Substance Act (CSA).

Hydrochlorothiazide and moexipril hydrochloride

Imprint:

G 206

Strength:

12.5 mg / 15 mg

Color:

White

Shape:

Elliptical / Oval

Availability:

Prescription only

Drug Class:

Angiotensin converting enzyme inhibitors

Pregnancy Category:

D - Positive evidence of risk

CSA Schedule:

Not a controlled drug

Manufacturer:

Glenmark Generics Inc.

National Drug Code (NDC):

68462-0206

Inactive Ingredients:

crospovidone
lactose monohydrate
magnesium oxide
magnesium stearate
povidone
hydroxypropyl cellulose (type h)
hypromelloses
polyethylene glycol 6000
titanium dioxide

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.